Cargando…
In Silico Screening and Identification of Antidiabetic Inhibitors Sourced from Phytochemicals of Philippine Plants against Four Protein Targets of Diabetes (PTP1B, DPP-4, SGLT-2, and FBPase)
Current oral medications for type 2 diabetes target a single main physiological mechanism. They either activate or inhibit receptors to enhance insulin sensitivity, increase insulin secretion, inhibit glucose absorption, or inhibit glucose production. In advanced stages, combination therapy may be r...
Autores principales: | Macalalad, Mark Andrian B., Gonzales, Arthur A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384415/ https://www.ncbi.nlm.nih.gov/pubmed/37513175 http://dx.doi.org/10.3390/molecules28145301 |
Ejemplares similares
-
Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach
por: Srivastava, Shivani, et al.
Publicado: (2017) -
Targeting FBPase is an emerging novel approach for cancer therapy
por: Liu, Gao-Min, et al.
Publicado: (2018) -
Toward the Prediction of FBPase Inhibitory Activity Using Chemoinformatic Methods
por: Hao, Ming, et al.
Publicado: (2012) -
Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
por: Icard, Philippe, et al.
Publicado: (2018) -
Relook at DPP-4 inhibitors in the era of SGLT-2 inhibitors
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)